Annual Long Term Debt
$1.74 B
+$15.82 M+0.92%
31 December 2023
Summary:
BridgeBio Pharma annual long term debt is currently $1.74 billion, with the most recent change of +$15.82 million (+0.92%) on 31 December 2023. During the last 3 years, it has risen by +$14.48 million (+0.84%). BBIO annual long term debt is now at all-time high.BBIO Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$1.73 B
+$491.00 K+0.03%
30 September 2024
Summary:
BridgeBio Pharma quarterly long term debt is currently $1.73 billion, with the most recent change of +$491.00 thousand (+0.03%) on 30 September 2024. Over the past year, it has dropped by -$10.56 million (-0.61%). BBIO quarterly long term debt is now -0.61% below its all-time high of $1.74 billion, reached on 31 December 2023.BBIO Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BBIO Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -0.6% |
| 3 y3 years | +0.8% | +0.2% |
| 5 y5 years | +1790.9% | +1779.4% |
BBIO Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +0.9% | -0.6% | +1.0% |
| 5 y | 5 years | at high | +1790.9% | -0.6% | +1779.4% |
| alltime | all time | at high | +3084.4% | -0.6% | +3065.0% |
BridgeBio Pharma Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.73 B(+0.0%) |
| June 2024 | - | $1.72 B(+0.0%) |
| Mar 2024 | - | $1.72 B(-0.7%) |
| Dec 2023 | $1.74 B(+0.9%) | $1.74 B(+0.3%) |
| Sept 2023 | - | $1.73 B(+0.1%) |
| June 2023 | - | $1.73 B(+0.3%) |
| Mar 2023 | - | $1.73 B(+0.3%) |
| Dec 2022 | $1.72 B(-0.1%) | $1.72 B(+0.5%) |
| Sept 2022 | - | $1.71 B(+0.2%) |
| June 2022 | - | $1.71 B(-0.9%) |
| Mar 2022 | - | $1.72 B(+0.1%) |
| Dec 2021 | $1.72 B | $1.72 B(+23.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $1.39 B(+0.1%) |
| June 2021 | - | $1.39 B(+1.2%) |
| Mar 2021 | - | $1.38 B(+180.3%) |
| Dec 2020 | $490.53 M(+434.4%) | $490.53 M(+2.2%) |
| Sept 2020 | - | $480.13 M(+0.9%) |
| June 2020 | - | $475.68 M(+1.2%) |
| Mar 2020 | - | $470.02 M(+412.1%) |
| Dec 2019 | $91.79 M(+68.4%) | $91.79 M(+22.4%) |
| Sept 2019 | - | $75.02 M(+0.0%) |
| June 2019 | - | $75.00 M(+36.7%) |
| Mar 2019 | - | $54.86 M(+0.6%) |
| Dec 2018 | $54.51 M | $54.51 M |
FAQ
- What is BridgeBio Pharma annual long term debt?
- What is the all time high annual long term debt for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly long term debt?
- What is the all time high quarterly long term debt for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly long term debt year-on-year change?
What is BridgeBio Pharma annual long term debt?
The current annual long term debt of BBIO is $1.74 B
What is the all time high annual long term debt for BridgeBio Pharma?
BridgeBio Pharma all-time high annual long term debt is $1.74 B
What is BridgeBio Pharma quarterly long term debt?
The current quarterly long term debt of BBIO is $1.73 B
What is the all time high quarterly long term debt for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly long term debt is $1.74 B
What is BridgeBio Pharma quarterly long term debt year-on-year change?
Over the past year, BBIO quarterly long term debt has changed by -$10.56 M (-0.61%)